Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Terminal Malignant Tumors”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Not applicableLooking for participantsNCT05797649
What this trial is testing

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Who this might be right for
Pleural EffusionHeart FailureMalignant Neoplasm+5 more
Chinese University of Hong Kong 120
Testing effectiveness (Phase 2)Study completedNCT00067288
What this trial is testing

Meaning-Centered Psychotherapy in Advanced Cancer

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
National Center for Complementary and Integrative Health (NCCIH) 118
Large-scale testing (Phase 3)UnknownNCT00417053
What this trial is testing

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Testing effectiveness (Phase 2)Ended earlyNCT02711137
What this trial is testing

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 137
Early research (Phase 1)Ended earlyNCT02698176
What this trial is testing

A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006)

Who this might be right for
NUT Midline Carcinoma (NMC)Triple Negative Breast Cancer (TNBC)Non-small Cell Lung Cancer (NSCLC)+1 more
Merck Sharp & Dohme LLC 13
Not applicableWithdrawnNCT03577600
What this trial is testing

Compassionate Treatment in Children With Brain Tumors With the Cytotron®

Who this might be right for
Pediatric Brain Tumor
Hospital Infantil de Mexico Federico Gomez
Testing effectiveness (Phase 2)UnknownNCT04520386
What this trial is testing

OMT-111 for Terminal Stage Solid Tumors

Who this might be right for
Breast CancerPancreatic CancerLung Cancer
MetiMedi Pharmaceuticals 78
Not applicableStudy completedNCT05118802
What this trial is testing

Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 46
Testing effectiveness (Phase 2)Study completedNCT02419417
What this trial is testing

Study of BMS-986158 in Subjects With Select Advanced Cancers

Who this might be right for
Advanced Tumors
Bristol-Myers Squibb 83
Testing effectiveness (Phase 2)Looking for participantsNCT04686682
What this trial is testing

A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

Who this might be right for
NSCLCSCLCCRPC+5 more
Jacobio Pharmaceuticals Co., Ltd. 152
Early research (Phase 1)Study completedNCT03936465
What this trial is testing

Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer

Who this might be right for
Solid Tumor, ChildhoodLymphomaBrain Tumor, Pediatric
Dana-Farber Cancer Institute 41
Not applicableStudy completedNCT01358617
What this trial is testing

Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+2 more
Children's Oncology Group 90
Early research (Phase 1)UnknownNCT04805060
What this trial is testing

Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors

Who this might be right for
Terminal Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Not applicableStudy completedNCT07164352
What this trial is testing

Effect of Breathing Exercises on Pain, Dyspnea, and Function in Terminal-Stage Cancer Patients

Who this might be right for
Palliative PatientsTerminal Malignant TumorsBreathing Techniques
Atlas University 58
Testing effectiveness (Phase 2)Ended earlyNCT02296476
What this trial is testing

A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)

Who this might be right for
Glioblastoma Multiforme
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 12
Not applicableStudy completedNCT03746392
What this trial is testing

Project to Improve Communication About Serious Illness - Pilot Study

Who this might be right for
Malignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more
University of Washington 150
Testing effectiveness (Phase 2)WithdrawnNCT02986919
What this trial is testing

Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Peripheral Nerve Tumors
University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT02259114
What this trial is testing

A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)

Who this might be right for
NUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Early research (Phase 1)Study completedNCT04587479
What this trial is testing

A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors, Adult
Jacobio Pharmaceuticals Co., Ltd. 41
Not applicableStudy completedNCT02970617
What this trial is testing

Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients

Who this might be right for
DistressMalignant Neoplasm
University of Southern California 82
Load More Results